Free Trial

Moderna CEO Expects Vaccine Interim Results In November (WSJ)

MARKET TALK

Moderna Inc. Chief Executive Stéphane Bancel said the federal government could authorize emergency use of the company's experimental Covid-19 vaccine in December, if the company gets positive interim results in November from a large clinical trial. Mr. Bancel, speaking during The Wall Street Journal's annual Tech Live conference Monday, said sufficient interim results from the study takes longer to get, government authorization of the vaccine may not occur until early next year.

MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.